Mink Therapeutics Inc

Biotech Stocks Healthcare Stocks

$12.11

-0.07 (-0.57%)

As of Sep 28, 10:29 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +64.9% upside

Low Target $17.96

Average Target $19.97

High Target $26.10

Current Price $12.11

Current
$12.11

Target
$19.97

$17.96 $19.97 avg $26.10

Scenario Analysis

Bear Case

$17.96

48.3%

Low target

Base Case

$19.97

+64.9%

Avg target

Bull Case

$26.10

+115.5%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$16.93

-28.5% from high

52-Week Low

$8.48

+42.8% from low

Target vs 52W High

$19.97

+18.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-26.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.2%